Neurogene Ownership | Who Owns Neurogene?
Neurogene Ownership Summary
Neurogene is owned by 73.07% institutional investors, 9.27% insiders, and 17.66% retail investors. Samsara biocapital is the largest institutional shareholder, holding 8.16% of NGNE shares.
NGNE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Neurogene | 73.07% | 9.27% | 17.66% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Samsara biocapital | 1.72M | 8.16% | $25.67M |
| Rtw investments, lp | 1.36M | 6.47% | $20.37M |
| Casdin capital | 1.30M | 6.15% | $19.37M |
| Redmile group | 1.28M | 6.06% | $19.09M |
| Baker bros. advisors lp | 991.69K | 4.71% | $14.83M |
| Blackrock funding, inc. /de | 977.68K | 4.64% | $14.62M |
| Toronto dominion bank | 681.34K | 3.24% | $10.19M |
| Arrowmark colorado | 585.40K | 2.78% | $8.75M |
| Great point partners | 485.86K | 2.31% | $7.26M |
| Jennison associates | 167.56K | 0.80% | $2.51M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 1.72M | 5.25% | $25.67M |
| Great point partners | 485.86K | 4.72% | $7.26M |
| Redmile group | 1.28M | 2.03% | $19.09M |
| Casdin capital | 1.30M | 1.76% | $19.37M |
| Rtw investments, lp | 1.36M | 0.29% | $20.37M |
| Dafna capital management | 51.10K | 0.21% | $763.88K |
| Arrowmark colorado | 585.40K | 0.16% | $8.75M |
| Baker bros. advisors lp | 991.69K | 0.14% | $14.83M |
| Rock springs capital management lp | 104.34K | 0.10% | $1.56M |
| Adar1 capital management | 29.63K | 0.07% | $442.89K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Toronto dominion bank | 681.34K | 0.02% | 442.08K |
| Arrowmark colorado | 585.40K | 0.16% | 143.81K |
| Jennison associates | 167.56K | 0.00% | 59.48K |
| Readystate asset management lp | 31.71K | 0.01% | 31.71K |
| Schroder investment management group | 30.18K | 0.00% | 30.18K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | 991.69K | 0.14% | -494.51K |
| Deerfield management company, l.p. (series c) | - | - | -446.88K |
| Blackrock funding, inc. /de | 977.68K | 0.00% | -421.45K |
| Price t rowe associates inc /md/ | - | - | -123.29K |
| Deep track capital, lp | - | - | -116.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Readystate asset management lp | 31.71K | 0.01% | 31.71K | $474.08K |
| Schroder investment management group | 30.18K | 0.00% | 30.18K | $451.15K |
| Rothschild investment | 55.00 | 0.00% | 55.00 | $822.00 |
| Versant capital management | 33.00 | 0.00% | 33.00 | $493.00 |
| Raymond james financial | 8.00 | - | 8.00 | $120.00 |
Sold Out
| Holder | Change |
|---|---|
| Corecap advisors | -11.00 |
| Coldstream capital management | -20.00 |
| Signaturefd | -22.00 |
| Physician wealth advisors | -29.00 |
| Creative planning | -41.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 83 | -3.49% | 15,385,506 | 2.02% | 73 | 1.42% | 39 | -11.36% | 27 | 17.39% |
| Mar 31, 2025 | 88 | -3.30% | 16,456,922 | 3.74% | 78 | 0.90% | 45 | -22.41% | 23 | 43.75% |
| Dec 31, 2024 | 92 | 8.24% | 16,089,357 | 16.19% | 94 | 1.42% | 58 | 31.82% | 17 | -22.73% |
| Sep 30, 2024 | 85 | 28.79% | 13,847,659 | 4.39% | 81 | 1.33% | 44 | 4.76% | 22 | 57.14% |
| Jun 30, 2024 | 66 | 10.00% | 13,265,527 | 9.37% | 78 | 1.52% | 42 | -2.33% | 14 | 55.56% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 14, 2025 | Cobb Stuart | Chief Scientific Officer | Sell | $103.00K |
| Mar 13, 2025 | Cvijic Christine Mikail | President and CFO | Sell | $76.25K |
| Nov 26, 2024 | Samsara BioCapital GP, LLC | - | Buy | $406.80K |
| Nov 26, 2024 | Samsara BioCapital GP, LLC | - | Buy | $516.83K |
| Nov 26, 2024 | Samsara BioCapital GP, LLC | - | Buy | $280.99K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 1 |
| 2024 Q4 | 6 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
NGNE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools